Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when NPCE files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: NPCE NeuroPace Inc 8-K

NeuroPace completes routine annual meeting, re-elects directors through 2029

Filed June 8, 2026 · Period ending June 5, 2026 · ~1 min read

2 key changes 1 section

Key Changes

  • low

    Stockholders re-elected Lisa Andrade and Scott Huennekens as Class II directors to serve three-year terms until the 2029 annual meeting. Both nominees received majority support with Huennekens garnering 99% approval.

  • low

    Stockholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 with 99% approval. No change in auditor relationship.

Summary

NeuroPace held its 2026 Annual Meeting on June 5, filing routine results with the SEC. The meeting covered standard governance matters: re-electing two Class II directors to three-year terms and ratifying the company's existing auditor for another year. Both proposals passed with strong shareholder support.

For retail investors, this filing represents normal corporate housekeeping with no material business developments. The director elections maintain board continuity, with both incumbents securing their seats through 2029. The auditor ratification confirms PwC will continue in its existing role. Investors should watch for NeuroPace's next quarterly earnings report for actual business performance updates, as annual meeting filings typically contain no financial or operational news.

Section-by-Section Diff

Event · Item 5.07 — Submission of Matters to a Vote of Security Holders

~300 words

NeuroPace held its 2026 Annual Meeting on June 5, 2026, electing two Class II directors and ratifying PwC as auditor for fiscal 2026.

2 Added
Show 2 minor / wording changes
Added Director elections low

Added in current filing · verify on EDGAR →

NeuroPace’s stockholders elected each of the following Class II director nominees to hold office until NeuroPace’s 2029 Annual Meeting of Stockholders and until their successor is duly elected and qualified or until their earlier death, resignation or removal.

Stockholders elected Lisa Andrade and Scott Huennekens as Class II directors to serve until the 2029 Annual Meeting. Andrade received 15,194,450 votes for with 6,024,133 withheld, while Huennekens received 20,973,382 votes for with 245,201 withheld. Both elections had 8,048,133 broker non-votes.

Added Auditor ratification low

Added in current filing · verify on EDGAR →

NeuroPace’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as NeuroPace’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Stockholders ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026. The vote passed with 28,850,105 votes for, 209,301 against, and 207,310 abstentions. This is a routine annual approval with no change in auditor.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify